Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1996-12-27
pubmed:databankReference
pubmed:abstractText
BALB/c mice are highly susceptible to infection with the protozoan parasite Leishmania major. This susceptibility has been attributed, in part, to the expansion of parasite-specific CD4+ Th2 cells that antagonize Th1 responses and promote humoral immunity. In the present study, we have utilized sera from L. major-infected BALB/c mice to screen an L. major amastigote cDNA expression library. One of the clones detected encodes a novel Ag designated as L. major stress-inducible 1 (LmSTI1). LmSTI1 contains six copies of the tetratricopeptide consensus motif and is highly related to a family of stress-inducible proteins that is conserved from yeast to humans. Sera from L. major-infected BALB/c mice have LmSTI1-specific Ab titers in excess of 1:200,000, comprised predominantly of IgG1, IgG2A, and IgG2B isotypes. Recombinant LmSTI1 protein elicited strong proliferative responses from draining lymph node cells of L. major-infected BALB/c mice at both early (10 days) and late (28 days) stages of infection and elicited production of high levels of IFN-gamma and low levels of IL-4. In contrast, soluble leishmanial lysate elicited high levels of IL-4 and low IFN-gamma production. Thus, we have identified an Ag of Leishmania capable of eliciting a mixed cellular response that is skewed toward a Th1 phenotype in susceptible BALB/c mice with advanced infections. In addition, analyses of sera from human patients with cutaneous, visceral, and post-kala azar visceral leishmaniasis indicated that a majority of individuals from all three clinical groups mounted strong humoral responses against LmSTI1.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
157
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5034-41
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:8943412-Amino Acid Sequence, pubmed-meshheading:8943412-Animals, pubmed-meshheading:8943412-Antibodies, Protozoan, pubmed-meshheading:8943412-Antigens, Protozoan, pubmed-meshheading:8943412-Base Sequence, pubmed-meshheading:8943412-Cloning, Molecular, pubmed-meshheading:8943412-DNA, Protozoan, pubmed-meshheading:8943412-Disease Models, Animal, pubmed-meshheading:8943412-Female, pubmed-meshheading:8943412-Genes, Protozoan, pubmed-meshheading:8943412-Humans, pubmed-meshheading:8943412-Interferon-gamma, pubmed-meshheading:8943412-Interleukin-4, pubmed-meshheading:8943412-Leishmania major, pubmed-meshheading:8943412-Leishmaniasis, Cutaneous, pubmed-meshheading:8943412-Mice, pubmed-meshheading:8943412-Mice, Inbred BALB C, pubmed-meshheading:8943412-Molecular Sequence Data, pubmed-meshheading:8943412-T-Lymphocytes
pubmed:year
1996
pubmed:articleTitle
Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
pubmed:affiliation
Infectious Disease Research Institute, Seattle, WA 98104, USA.
pubmed:publicationType
Journal Article, In Vitro, Research Support, U.S. Gov't, P.H.S.